Cargando…
Efficient Delivery of Genome-Editing Proteins In Vitro and In Vivo
Efficient intracellular delivery of proteins is needed to fully realize the potential of protein therapeutics. Current methods of protein delivery commonly suffer from low tolerance for serum, poor endosomal escape, and limited in vivo efficacy. Here we report that common cationic lipid nucleic acid...
Autores principales: | Zuris, John A., Thompson, David B., Shu, Yilai, Guilinger, John P., Bessen, Jeffrey L., Hu, Johnny H., Maeder, Morgan L., Joung, J. Keith, Chen, Zheng-Yi, Liu, David R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289409/ https://www.ncbi.nlm.nih.gov/pubmed/25357182 http://dx.doi.org/10.1038/nbt.3081 |
Ejemplares similares
-
Efficient In Vivo Genome Editing Using RNA-Guided Nucleases
por: Hwang, Woong Y., et al.
Publicado: (2013) -
Treatment of autosomal dominant hearing loss by in
vivo delivery of genome editing agents
por: Gao, Xue, et al.
Publicado: (2017) -
Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo
por: Tao, Yong, et al.
Publicado: (2023) -
Small Molecule-Triggered Cas9 Protein with Improved Genome-Editing Specificity
por: Davis, Kevin M., et al.
Publicado: (2015) -
Continuous directed evolution of DNA-binding proteins to improve TALEN specificity
por: Hubbard, Basil P., et al.
Publicado: (2015)